Evidence map›Paper›PMID 25742273›Full record

ArticleMemorias do Instituto Oswaldo Cruz2015

The use of halloysite clay and carboxyl-functionalised multi-walled carbon nanotubes for recombinant LipL32 antigen delivery enhanced the IgG response.

Daiane D Hartwig, Kátia L Bacelo, Thaís L Oliveira, Rodrigo Schuch, Fabiana K Seixas, Tiago Collares, Oscar Rodrigues, Cláudia P Hartleben, Odir A Dellagostin

Open access · diamondAbstract read
In one paragraph

Article in Memorias do Instituto Oswaldo Cruz, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.9field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 16 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Daiane D HartwigCentro de Desenvolvimento Tecnológico.
Kátia L BaceloCentro de Desenvolvimento Tecnológico.
Thaís L OliveiraCentro de Desenvolvimento Tecnológico.
Rodrigo SchuchCentro de Desenvolvimento Tecnológico.
Fabiana K SeixasCentro de Desenvolvimento Tecnológico.
Tiago CollaresCentro de Desenvolvimento Tecnológico.
Oscar RodriguesDepartamento de Química, Universidade Federal de Santa Maria, Santa Maria, RS, Brasil.
Cláudia P HartlebenCentro de Desenvolvimento Tecnológico.
Odir A DellagostinCentro de Desenvolvimento Tecnológico.
Universidade Federal de Pelotas · BRUniversidade Federal de Santa Maria · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We studied the feasibility of using halloysite clay nanotubes (HNTs) and carboxyl-functionalised multi-walled carbon nanotubes (COOH-MWCNTs) as antigen carriers to improve immune responses against a recombinant LipL32 protein (rLipL32). Immunisation using the HNTs or COOH-MWCNTs significantly increased the rLipL32-specific IgG antibody titres (p < 0.05) of Golden Syrian hamsters. None of the vaccines tested conferred protection against a challenge using a virulent Leptospira interrogans strain. These results demonstrated that nanotubes can be used as antigen carriers for delivery in hosts and the induction of a humoral immune response against purified leptospiral antigens used in subunit vaccine preparations.

Indexed as

Nanotubes, CarbonAluminum SilicatesAnimalsAntigensAntigens, BacterialBacterial Outer Membrane ProteinsBacterial VaccinesCarbon DioxideClayCricetinaeFeasibility StudiesImmunity, HumoralImmunoglobulin GLeptospira interrogansLipoproteinsMesocricetusAluminum SilicatesAntigensAntigens, BacterialBacterial Outer Membrane ProteinsBacterial VaccinesCarbon Dioxidecarboxyl radicalClayImmunoglobulin GLipL32 protein, LeptospiraLipoproteinsNanotubes, CarbonRecombinant Proteins

Identifiers

PMID25742273
PMCPMC4371227
OpenAlexW2046834095

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.